Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
15.9%
% of XLV's 64 holdings also in PJP
45.5%
% of PJP's 22 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 6.2% | 5.8% | 5.8% |
|
ELI LILLY & CO | 11.4% | 5.8% | 5.8% |
|
JOHNSON & JOHNSON | 6.8% | 5.4% | 5.4% |
|
ABBVIE INC | 5.3% | 5.2% | 5.2% |
|
ABBOTT LABORATORIES | 3.4% | 5.1% | 3.4% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to PJP
|
UNITEDHEALTH GROUP INC | 8.9% |
|
ELI LILLY & CO | 5.6% |
|
THERMO FISHER SCIENTIFIC INC | 4.3% |
|
DANAHER CORP | 3.1% |
|
INTUITIVE SURGICAL INC | 2.6% |
|
ELEVANCE HEALTH INC | 2.4% |
|
STRYKER CORP | 2.1% |
 |
MEDTRONIC PLC | 2.1% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
|
BOSTON SCIENTIFIC CORP | 2.0% |
XLV Underweight Relative to PJP
|
GERON CORP | -6.9% |
|
UNITED THERAPEUTICS CORP | -4.4% |
|
LIGAND PHARMACEUTICALS-CL B | -4.3% |
|
CORCEPT THERAPEUTICS INC | -4.3% |
|
BIOSANTE PHARMACEUTICALS INC | -4.1% |
|
REGENERON PHARMACEUTICALS | -4.0% |
|
SUPERNUS PHARMACEUTICALS INC | -3.7% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.6% |
|
INNOVIVA, INC. | -3.5% |
|
PACIRA PHARMACEUTICALS INC | -3.5% |